ROIV
Roivant Sciences Ltd. · Healthcare
Pres, Immunovant CEO Eric Venker sold $5.3M of Roivant Sciences Ltd.
Sold$5,298,000
$26.49Price
200,000Shares
−11%Stake
What ROIV did after the filing
- The stock from Thu, Feb 19 open, $27.27
- +3.9%
- S&P 500, same days
- −4.1%
Measured over 30 trading days, to the Apr 2 close.
Traded Fri, Feb 13. Filed Wed, Feb 18, 5:57 PM ET, after the close. Returns use the Feb 19 open and the Apr 2 close. Not investment advice.